Literature DB >> 20547308

Histopathological classification of hepatocellular carcinoma.

Massimo Roncalli1, Young Nyun Park, Luca Di Tommaso.   

Abstract

Recent advances in the understanding of HCC heterogeneity have shown not only distinct molecular classes with potential therapeutical implications but also have suggested that subclasses might be mirrored by tumour morphology and phenotype. The classification of HCC is therefore shifting from a more traditional, morphology-based approach to a more functional approach with clinical implications. The classical histological patterns (trabecular, pseudoglandular, solid, etc.) are still taken into account but in combination with other parameters such as cell grading, clonal changes, type and extent of vascularisation, tumour immunophenotype etc. This array of morpho-phenotypical features is expected to ultimately provide information about cell of origin, tumour behaviour and, hopefully, treatment sensitivity. In this chapter we will give a brief overview on modern principles of hepatic carcinogenesis by outlining the events/lesions bridging the microscopic dysplasia to advanced HCC. In this context special emphasis will be given to novel concepts and diagnostics and differential diagnosis of small HCC (of early and progressed type), which is the main target of the surveillance in the cirrhotic population. Novel and emerging subpopulations of HCC will also be considered, for example HCC with stem/progenitor cell phenotype and mixed hepatobiliary forms which are filling the traditional separation between two entities (HCC and cholangiocarcinoma), likely more inter-related than previously thought. Copyright 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20547308     DOI: 10.1016/S1590-8658(10)60510-5

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  19 in total

Review 1.  Radiological features of hepatocellular carcinoma.

Authors:  Samir Shah; Akash Shukla; Bhawan Paunipagar
Journal:  J Clin Exp Hepatol       Date:  2014-07-19

Review 2.  Histopathologic features of hepatocellular carcinoma.

Authors:  Elizabeth M Brunt
Journal:  Clin Liver Dis (Hoboken)       Date:  2013-01-23

Review 3.  Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Authors:  Elizabeth M Brunt; Valerie Paradis; Christine Sempoux; Neil D Theise
Journal:  Hepat Oncol       Date:  2015-07-28

Review 4.  Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers.

Authors:  Regina Cheuk-Lam Lo; Irene Oi-Lin Ng
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

5.  OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.

Authors:  Francesco Vasuri; Rita Golfieri; Michelangelo Fiorentino; Elisa Capizzi; Matteo Renzulli; Antonio D Pinna; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  Virchows Arch       Date:  2011-06-21       Impact factor: 4.064

6.  Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.

Authors:  Jung Il Lee; Jin-Woo Lee; Joon Mee Kim; Ja Kyung Kim; Hyun Jung Chung; Young Soo Kim
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

7.  Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits.

Authors:  Jens U Marquardt; Daekwan Seo; Jesper B Andersen; Matthew C Gillen; Myoung Soo Kim; Elizabeth A Conner; Peter R Galle; Valentina M Factor; Young Nyun Park; Snorri S Thorgeirsson
Journal:  J Hepatol       Date:  2013-10-26       Impact factor: 25.083

8.  Characterization of monocarboxylate transporter activity in hepatocellular carcinoma.

Authors:  Venâncio A Alves; Céline Pinheiro; Filipa Morais-Santos; Aloisio Felipe-Silva; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

9.  Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations.

Authors:  Aileen Wee
Journal:  Patholog Res Int       Date:  2011-06-30

10.  An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.

Authors:  Anh Tuan Nguyen; Alexander Emelyanov; Chor Hui Vivien Koh; Jan M Spitsbergen; Serguei Parinov; Zhiyuan Gong
Journal:  Dis Model Mech       Date:  2011-09-08       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.